Literature DB >> 24896138

Choroidal thickness in macular telangiectasia type 2.

Jay Chhablani1, Igor Kozak, Ganesh Babu Jonnadula, Amarnath Venkata, Raja Narayanan, Rajeev Reddy Pappuru, Podili Srinivas Rao.   

Abstract

PURPOSE: To assess the choroidal thickness changes in eyes with macular telangiectasia Type 2 and their relationship with the integrity of outer retinal structures and visual acuity.
METHODS: This is a prospective observational study that included 81 eyes (41 subjects) with macular telangiectasia Type 2, including 21 women who underwent enhanced depth choroidal imaging. The choroidal thickness measurements were made at the fovea and at 5 points with an interval of 500 μm in both directions, nasal and temporal from the fovea, and were compared with age-matched healthy subjects. Masked observers assessed the outer retinal structure integrity. Stepwise regression was used to find the relationship between age, spherical equivalent, central macular thickness, integrity of the inner segment/outer segment junction, external limiting membrane integrity, and subfoveal choroidal thickness (SFCT).
RESULTS: The mean age of the subjects was 55.2 ± 7.8 years in study subjects. The mean SFCT was 274.6 ± 45.7 μm. There was no significant difference between the SFCT in eyes with macular telangiectasia Type 2 and age-matched healthy subjects (P = 0.38). There was no correlation between the visual acuity (r = 0.008); integrity of inner segment/outer segment (r = 0.54); external limiting membrane (r = 0.47); central macular thickness (r = 0.31) and SFCT.
CONCLUSION: Choroidal thickness did not vary between eyes with macular telangiectasia Type 2 and age-matched healthy subjects. There was no correlation between SFCT and visual acuity, and integrity of the outer retinal structures and central macular thickness.

Entities:  

Mesh:

Year:  2014        PMID: 24896138     DOI: 10.1097/IAE.0000000000000180

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.

Authors:  Berna Dogan; Muhammet Kazim Erol; Melih Akidan; Elcin Suren; Yusuf Akar
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

2.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

3.  Choroidal thickness profile in inherited retinal diseases in Indian subjects.

Authors:  Jay Chhablani; Ashraya Nayaka; Padmaja Kumari Rani; Subhadra Jalali
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

4.  Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

Authors:  Müge Çoban Karataş; Gürsel Yılmaz; Aslıhan Yüce Sezen; Çağla Sarıtürk
Journal:  Turk J Ophthalmol       Date:  2022-02-23

5.  Choroidal vascularity index change in macular telangiectasia type 2.

Authors:  Heejeong Chun; Hyun Suh; Joo Young Kim; Jae Hyuck Kwak; Rae Young Kim; Mirinae Kim; Young-Gun Park; Young-Hoon Park
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

Review 6.  Macular Telangiectasia Type 2: A Comprehensive Review.

Authors:  Kiran Chandra Kedarisetti; Raja Narayanan; Michael W Stewart; Nikitha Reddy Gurram; Arshad M Khanani
Journal:  Clin Ophthalmol       Date:  2022-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.